Medicamen Biotech Limited

Medicamen Biotech Limited (MEDICAMEQ) is a micro-cap Healthcare company valued at ₹389 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Medicamen Biotech Limited last traded at ₹286.5, down 2.75% on the day.

Recent developments

On 2026-09-18, the company announced a dividend of ₹1.00 per share, ex-date. The domestic institutional holding increased by 0.40 percentage points in the quarter ending 2026-06-30.

Financial performance

The company's business has improved, with annual revenue rising 21.3% and net profit growing 40.0% year-over-year. However, the latest quarter showed revenue and net profit both rising compared to the same quarter a year earlier, with net profit margin expanding 0.7 percentage points to 5.0%.

Valuation multiples

The stock trades at 39.7 times earnings, a premium to the Healthcare median of 32.0, 1.51 times book value. It yields 0.3%.

Things to watch

The company's profit growth has slowed over the past five years, with a -4.0% CAGR. The return on equity is low at 3.5%, and the return on capital employed is also modest at 4.8%. The stock is 28.8% below its 52-week high.

Where it stands

The company has seen strong annual profit growth, but its five-year profit CAGR is negative. The stock is trading below its 52-week high, and the return on equity remains low. The latest quarter showed stable growth in both revenue and net profit.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.